These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7955222)
21. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias]. Zehender M Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958 [TBL] [Abstract][Full Text] [Related]
22. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Shiga T; Wajima Z; Inoue T; Ogawa R Am J Med; 2004 Sep; 117(5):325-33. PubMed ID: 15336582 [TBL] [Abstract][Full Text] [Related]
24. Interrelationship of magnesium and congestive heart failure. Seelig MS Wien Med Wochenschr; 2000; 150(15-16):335-41. PubMed ID: 11105329 [TBL] [Abstract][Full Text] [Related]
25. [Arrhythmia risk stratification in patients with heart failure. Foreword]. Opasich C; Santini M Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345 [TBL] [Abstract][Full Text] [Related]
30. Clinical inquiries. Does digoxin decrease morbidity for those in sinus rhythm with heart failure? Fotinos C; Nashelsky J J Fam Pract; 2005 Jun; 54(6):556-7. PubMed ID: 15939011 [No Abstract] [Full Text] [Related]
31. Whither withering? The role of digoxin in patients with heart failure due to systolic left ventricular dysfunction in sinus rhythm. Pitt B J Card Fail; 2006 Jun; 12(5):347-8. PubMed ID: 16762796 [No Abstract] [Full Text] [Related]
32. [Heart arrhythmias and congestive heart failure]. Abuladze GV; Narciia EV; Mamamtavrishvili ND; Nikolaishvili MG; Kantariia DA Georgian Med News; 2006 Apr; (133):41-4. PubMed ID: 16705224 [TBL] [Abstract][Full Text] [Related]
33. Heart rate variability in chronic heart failure: target for therapy? Sueta CA Am Heart J; 2003 Sep; 146(3):385-7. PubMed ID: 12947353 [No Abstract] [Full Text] [Related]
34. [Effect of potassium and magnesium salts in acute and chronic coronary insufficiency and its complications]. Lewandowicz J Wiad Lek; 1967 Apr; 20(11):1039-41. PubMed ID: 6075336 [No Abstract] [Full Text] [Related]
35. [Congestive heart failure and ventricular arrhythmia in relation to magnesium, potassium and sodium in serum and erythrocytes]. Bogdan M; Nartowicz E; Ukleja-Adamowicz M; Rozwodowska M Kardiol Pol; 1993 Jun; 38(6):417-20; discussion 421. PubMed ID: 8366653 [TBL] [Abstract][Full Text] [Related]
36. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Lilleberg J; Ylönen V; Lehtonen L; Toivonen L Scand Cardiovasc J; 2004 May; 38(2):80-4. PubMed ID: 15204232 [TBL] [Abstract][Full Text] [Related]
37. Update on digoxin therapy in congestive heart failure. Haji SA; Movahed A Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703 [TBL] [Abstract][Full Text] [Related]
38. [Heart rate variability, arrhythmia and magnesium in hemodialysis patients]. Yokoyama A; Kikuchi K; Kawamura Y Clin Calcium; 2005 Feb; 15(2):226-32. PubMed ID: 15692161 [TBL] [Abstract][Full Text] [Related]
39. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation. Billman GE J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569 [TBL] [Abstract][Full Text] [Related]
40. [Prevention of complications: a forgotten aspect of therapy? arrhythmia complication in heart failure]. de Sousa J Rev Port Cardiol; 2001 Mar; 20 Suppl 3():33-8. PubMed ID: 11409072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]